DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Iwata H, Tamura K, Doi T. et al.
Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: long-term results of a large phase 1 study with multiple expansion cohorts.
J Clin Oncol 2018;
36: 2501
Access:
We do not assume any responsibility for the contents of the web pages of other providers.